Search research articles
Contact Us
Filters
Showing results (201-210 of 233) with videos related to
Page
of 24
Sort By:
European Journal of Pediatrics
|
September 5, 2020
Intravenous paracetamol in comparison with ibuprofen for the treatment of patent ductus arteriosus in preterm infants: a randomized controlled trial
Carlo Dani, Gianluca Lista, Silvia Bianchi, et al.
Minerva Cardiology and Angiology
|
November 16, 2023
Blockchain technology in Cardiovascular Medicine: a glance to the future? Results from a social media survey and future perspectives
Luigi Spadafora, Gian L Comandini, Salvatore Giordano, et al.
Virology Journal
|
January 7, 2022
Analysis of HIV quasispecies and virological outcome of an HIV D+/R+ kidney-liver transplantation
Gabriella Rozera, Ubaldo Visco-Comandini, Emanuela Giombini, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 19, 2017
The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real-life experience
Silvia Martini, Maria Francesca Donato, Chiara Mazzarelli, et al.
Annals of Hepatology
|
April 27, 2019
Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study
Raffaella Lionetti, Paola Piccolo, Ilaria Lenci, et al.
Cancer
|
August 5, 2020
Pharmacokinetics, safety, and activity of trabectedin as first-line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma Group
Federica Grosso, Lorenzo D'Ambrosio, Massimo Zucchetti, et al.
AIDS Research and Human Retroviruses
|
August 9, 2002
Monophyletic HIV type 1 CRF02-AG in a nosocomial outbreak in Benghazi, Libya
Ubaldo Visco-Comandini, Giuseppina Cappiello, Giuseppina Liuzzi, et al.
The Journal of Antimicrobial Chemotherapy
|
August 8, 2006
Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment
Stefano Aquaro, Roberta D'Arrigo, Valentina Svicher, et al.
Clinical Transplantation
|
December 2, 2017
Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study
Raffaella Lionetti, Vincenza Calvaruso, Paola Piccolo, et al.
The Journal of Infectious Diseases
|
April 19, 2008
Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure
Valentina Svicher, Stefano Aquaro, Roberta D'Arrigo, et al.
Page
of 24
Search research articles
Search
Showing results (201-210 of 233) with videos related to
Sort By:
Page
of 24
European Journal of Pediatrics
|
September 5, 2020
Intravenous paracetamol in comparison with ibuprofen for the treatment of patent ductus arteriosus in preterm infants: a randomized controlled trial
Carlo Dani, Gianluca Lista, Silvia Bianchi, et al.
Minerva Cardiology and Angiology
|
November 16, 2023
Blockchain technology in Cardiovascular Medicine: a glance to the future? Results from a social media survey and future perspectives
Luigi Spadafora, Gian L Comandini, Salvatore Giordano, et al.
Virology Journal
|
January 7, 2022
Analysis of HIV quasispecies and virological outcome of an HIV D+/R+ kidney-liver transplantation
Gabriella Rozera, Ubaldo Visco-Comandini, Emanuela Giombini, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 19, 2017
The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real-life experience
Silvia Martini, Maria Francesca Donato, Chiara Mazzarelli, et al.
Annals of Hepatology
|
April 27, 2019
Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study
Raffaella Lionetti, Paola Piccolo, Ilaria Lenci, et al.
Cancer
|
August 5, 2020
Pharmacokinetics, safety, and activity of trabectedin as first-line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma Group
Federica Grosso, Lorenzo D'Ambrosio, Massimo Zucchetti, et al.
AIDS Research and Human Retroviruses
|
August 9, 2002
Monophyletic HIV type 1 CRF02-AG in a nosocomial outbreak in Benghazi, Libya
Ubaldo Visco-Comandini, Giuseppina Cappiello, Giuseppina Liuzzi, et al.
The Journal of Antimicrobial Chemotherapy
|
August 8, 2006
Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment
Stefano Aquaro, Roberta D'Arrigo, Valentina Svicher, et al.
Clinical Transplantation
|
December 2, 2017
Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study
Raffaella Lionetti, Vincenza Calvaruso, Paola Piccolo, et al.
The Journal of Infectious Diseases
|
April 19, 2008
Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure
Valentina Svicher, Stefano Aquaro, Roberta D'Arrigo, et al.
Page
of 24